Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Predictive Capacity of Plasma and Urinary Biomarkers for Persistent Albuminuria in Patients with Sickle Cell Disease

Laila Elsherif, Vimal K. Derebail, Yihan Tang, Lara C. Scott, Kammie L. Patillo, David Wichlan, Kristina Landes, Paula McCune, Laura R. Loehr, Payal Desai, Robert Cronin, Laura Y. Zhou, Fei Zou, Jianwen Cai, David M. Pollock, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 3897.

https://doi.org/10.1182/blood-2023-187610

Published: 2023

Journal Articles

ETA Receptor Blockade and Vascular Function in Patients with Sickle Cell Disease

Daniel Adamkiewicz, Hongyan Xu, PhD, Latanya Bowman, RN, Leigh Wells, MSN, Niren Patel, MBBS, Ryan Harris, PhD CEP, FACSM, Jennifer Pollock, PhD, David M. Pollock, PhD, Steffen E. Meiler, MD, Abdullah Kutlar, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142477

Published: 2020

Journal Articles

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Abdullah Kutlar, MD, Jennifer Pollock, PhD, Steffen E. Meiler, MD, Ryan Harris, PhD CEP, FACSM, Xu Hongyan, PhD, Leigh Wells, MSN, Latanya Bowman, RN, Sharon Jones, BS, David M. Pollock, PhD

Blood (2019) 134 (Supplement_1): 617.

https://doi.org/10.1182/blood-2019-130036

Published: 2019

Journal Articles

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Erica Sparkenbaugh, PhD BS, Kathryn Wilson, BS, Malgorzata Kasztan, PhD, David M. Pollock, PhD, Keith R. McCrae, MD, Rafal Pawlinski, PhD

Blood (2018) 132 (Supplement 1): 268.

https://doi.org/10.1182/blood-2018-99-116526

Published: 2018

Journal Articles

Endothelin-1 Is Associated with Albuminuria and Measures of Vascular Endothelial Dysfunction in Sickle Cell Anemia

Vimal K. Derebail, MD MPH, Susan K Jones, RN, Jessica Shen, BS, Melissa Caughey, PhD, Alan L. Hinderliter, MD, David M. Pollock, PhD, David R. Archer, PhD, Kenneth I. Ataga, MD

Blood (2015) 126 (23): 983.

https://doi.org/10.1182/blood.V126.23.983.983

Published: 2015

Journal Articles

Gender Differences In Renal Blood Flow In Response To Endothelin-1 In a Mouse Model Of Sickle Cell Disease

J Brett Heimlich, Matthew J McGhee, Steffen E. Meiler, MD, Abdullah Kutlar, MD, David M Pollock, PhD

Blood (2013) 122 (21): 1012.

https://doi.org/10.1182/blood.V122.21.1012.1012

Published: 2013

NARROW

Predictive Capacity of Plasma and Urinary Biomarkers for Persistent Albuminuria in Patients with Sickle Cell Disease

ETA Receptor Blockade and Vascular Function in Patients with Sickle Cell Disease

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Endothelin-1 Is Associated with Albuminuria and Measures of Vascular Endothelial Dysfunction in Sickle Cell Anemia

Gender Differences In Renal Blood Flow In Response To Endothelin-1 In a Mouse Model Of Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Predictive Capacity of Plasma and Urinary Biomarkers for Persistent Albuminuria in Patients with Sickle Cell Disease

ETA Receptor Blockade and Vascular Function in Patients with Sickle Cell Disease

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Endothelin-1 Is Associated with Albuminuria and Measures of Vascular Endothelial Dysfunction in Sickle Cell Anemia

Gender Differences In Renal Blood Flow In Response To Endothelin-1 In a Mouse Model Of Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only